Company Filing History:
Years Active: 2021
Title: Rudolf Mitterbauer: Innovator in Enzymatic Detoxification
Introduction
Rudolf Mitterbauer is a notable inventor based in Scheffau am Wilden Kaiser, Austria. He has made significant contributions to the field of enzymatic detoxification, particularly concerning zearalenone, a mycotoxin that poses risks to health.
Latest Patents
Mitterbauer holds a patent for a polypeptide designed for the enzymatic detoxification of zearalenone. This invention involves a monooxygenase that converts the keto group in position 7 of zearalenone into an ester group. The patent details that the monooxygenase is an amino acid sequence selected from a specific group, with functional variants exhibiting a sequence identity of at least 60% to 90%. He has 1 patent to his name.
Career Highlights
Rudolf Mitterbauer is associated with Erber Aktiengesellschaft, a company known for its innovative solutions in the agricultural sector. His work focuses on developing methods to mitigate the effects of harmful substances in food production.
Collaborations
Mitterbauer has collaborated with notable colleagues, including Juan Antonio Torres Acosta and Gerhard Adam. These partnerships have contributed to advancing research and development in his field.
Conclusion
Rudolf Mitterbauer's work in enzymatic detoxification represents a significant advancement in food safety and health. His innovative approach to addressing the challenges posed by zearalenone showcases the importance of research and collaboration in the field of biotechnology.